Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold
What I like: Brightening activities are familiar and market-relevant
Front Biosci Landmark 25(6):10581109 Smith CE, Bowen N, Graham WJ et al (2015) Activation of Saccharomyces cerevisiae Mlh1-Pms1 endonuclease in a reconstituted mismatch repair system
The medication works by mimicking the natural GLP-1 hormone, which helps regulate appetite, slow digestion, and support feelings of fullness, making it easier to follow a reduced-calorie diet
If your symptoms or conditions arent chronic, then a Myers cocktail once a month is probably enough
Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP